- Conditions
- Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism, Obesity, Metabolic Syndrome
- Interventions
- Not listed
- Lead sponsor
- Ali Chappell
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Mild Cognitive Impairment, Metabolic Syndrome
- Interventions
- Dietary intervention
- Behavioral
- Lead sponsor
- Bristlecone Health, Inc.
- Industry
- Eligibility
- 35 Years to 80 Years
- Enrollment
- 98 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Maple Grove, Minnesota
- Conditions
- Obesity & Overweight, Mobility Disability, HOMA-IR
- Interventions
- Enobosarm, Semaglutide (Wegovy) weekly injection
- Drug
- Lead sponsor
- Veru Inc.
- Industry
- Eligibility
- 65 Years to 100 Years
- Enrollment
- 239 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 13
- States / cities
- Phoenix, Arizona • Doral, Florida • Miami, Florida + 7 more
- Conditions
- Visceral Obesity, Insulin Resistance
- Interventions
- Water-only fasting
- Other
- Lead sponsor
- TrueNorth Health Foundation
- Other
- Eligibility
- 40 Years to 70 Years
- Enrollment
- 48 participants
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Santa Rosa, California
- Conditions
- Impaired Glucose Tolerance, Insulin Resistance
- Interventions
- LIM-0705, Placebo capsules
- Drug
- Lead sponsor
- Limerick BioPharma
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 1
- States / cities
- Chula Vista, California
- Conditions
- Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE), Preeclampsia (PE) Risk, Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy, Cardiometabolic Diseases, Insulin Resistance, Placental Dysfunction, Pregnancy, Pregnancy Complications, Gestational Complications
- Interventions
- Not listed
- Lead sponsor
- University of Tennessee Graduate School of Medicine
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Knoxville, Tennessee